Anaplastic lymphoma kinase (ALK), which encodes a tyrosine kinase member of the insulin receptor superfamily, was initially identified as a potent oncogenic driver in anaplastic large-cell lymphoma (ALCL) [1, 2]. Here, INSR is linked to anaplastic large cell lymphoma.